SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Monarch Medical Technologies and Voluntis to Host Webinar on Use of Technology to Support Inpatient and Outpatient Insulin Management
[June 17, 2019]

Monarch Medical Technologies and Voluntis to Host Webinar on Use of Technology to Support Inpatient and Outpatient Insulin Management


Despite advances in treatment and clear guidelines, many patients with diabetes are failing to achieve target glucose levels both in the inpatient and outpatient setting. One of the main challenges posing a barrier is clinical inertia preventing the initiation and intensification of insulin therapy. Insulin therapy has been proven to significantly reduce hemoglobin A1c levels in individuals with diabetes and better manage hyperglycemia, yet countless studies show that insulin initiation and intensification is frequently and inappropriately delayed.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005540/en/

Monarch and Voluntis, who formed a business relationship last year, are partnering to offer a complimentary webinar, "How Technology Can Support Adoption of Best Practices for Inpatient and Outpatient Insulin Management." The webinar will discuss the current challenges in initiating and managing insulin therapy, review the recommended practices in both the inpatient and outpatient setting, and discuss how technology can be used and implemented to benefit both patients and providers.

You may register for the webinar here.



When

Tuesday, June 25, 2019 at 12:00 pm EST


Speakers

Amy Butts PA-C, MPAS, CDE, BC-ADM, Endocrine Physician Assistant, Wheeling Hospital

Mark Vanderwel, MD, Medical Director of the Pediatric Endocrinology Division, Atrium Health

Learning Objectives

  • Discuss the difficulties that providers and patients have with managing insulin dosing
  • Review the 2019 ADA Standards of Medical Care in Diabetes for insulin management
  • Provide examples of how technology can support inpatient and outpatient insulin titration
  • Describe strategies to integrate technology into your environment

Following the live webinar, a recording will be available to download on monarchmedtech.com within 24 hours of the live event.

About Monarch Medical Technologies

Monarch Medical Technologies is the leading provider of electronic systems for inpatient glycemic management. Monarch's EndoTool® Glucose Management System offers personalized dosing recommendations for intravenous and subcutaneous insulin therapy. As a Class II FDA-cleared, patented software suite, EndoTool has been chosen by more than 300 hospitals to provide unsurpassed patient-specific glycemic control across a broad population of patients, and ultimately deliver better, safer care. For more information, please visit monarchmedtech.com.

About Voluntis

Voluntis creates digital therapeutics that empower people suffering from chronic conditions to self- manage their treatment every day, thus improving real-world outcomes. Combining mobile and web apps, Voluntis' solutions deliver personalized recommendations to the patient and the care team so that they can, for example, adjust treatment dosage, manage side effects or monitor symptoms. These real- time recommendations are based on digitized clinical algorithms. Leveraging its Theraxium technology platform, Voluntis has designed and operates multiple digital therapeutics, especially in diabetes and oncology. Voluntis has long-standing partnerships with leading life science companies such as Abbvie, AstraZeneca, Roche, Sanofi and Onduo. Based out of Boston and Paris, France, Voluntis is a founding member of the Digital Therapeutics Alliance. For further information: http://www.voluntis.com.
Voluntis is traded on the Euronext Paris - Compartment C market
Ticker: VTX - ISIN: FR0004183960

Diabeo® is a registered trademark of Sanofi. Insulia® is a registered trademark of Voluntis.

For further information: http://www.voluntis.com


[ Back To TMCnet.com's Homepage ]









Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2019 Technology Marketing Corporation. All rights reserved | Privacy Policy